MSE
BOLD

MUFG Securities EMEA’s Audentes Therapeutics, Inc BOLD Stock Holding History

MUFG Securities EMEA’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-190,000
Closed -$11.4M – 581
2019
Q4 		$11.4M Buy
+190,000
New +$7.13M 0.09% 188

MUFG Securities EMEA's BOLD Position: Q1 2020 in Review

MUFG Securities EMEA sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 190,000 shares — an estimated $11.4M sold.

MUFG Securities EMEA first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $11.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • MUFG Securities EMEA reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • MUFG Securities EMEA sold 190,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $11.4M.
  • MUFG Securities EMEA first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • MUFG Securities EMEA's Audentes Therapeutics, Inc position peaked at $11.4M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on MUFG Securities EMEA's 13F filing for Q1 2020, filed 12 May 2020.